Liu Sihao, Zhao Xia, Tang Junmei, Han Yuemei, Lin Quankui
School of Ophthalmology & Optometry, Eye Hospital, Wenzhou Medical University, 270 Xueyuan Road, Wenzhou 325027, China.
ACS Biomater Sci Eng. 2021 Mar 8;7(3):1065-1073. doi: 10.1021/acsbiomaterials.0c01705. Epub 2021 Jan 25.
Posterior capsular opacification (PCO) is the most important complication in cataract phacoemulsification and intraocular lens (IOL) implantation surgery, mainly stemming from the adhesion, proliferation, and transdifferentiation of the postsurgically residual lens epithelial cells (LECs). Previous investigations mainly focused on the hydrophilic surface modification of the IOLs for PCO prevention, such as heparinization. However, the long-term clinical investigations show that there is no significant difference between pristine and heparinized IOLs. In the present study, a synergetic coating with properties of drug-eluting and hydrophilicity was designed and modified onto the IOL surface via facile dopamine self-polymerization. The antiproliferative drug doxorubicin (DOX) was loaded when a polydopamine (PDA) coating was formed on the IOL surface. The hydrophilic 2-methacryloyloxyethyl phosphorylcholine (MPC) could be subsequently grafted onto the drug-loaded PDA coating surface easily. The hydrophilic outer layer could slow down drug-eluting from underneath the drug-incorporated coating. and investigations demonstrated that such multifunctionalized coating-modified IOLs could not only thoroughly and effectively prevent PCO development by induced cell apoptosis but also render safety and biocompatibility to the surrounding tissues.
后囊膜混浊(PCO)是白内障超声乳化吸除及人工晶状体(IOL)植入手术中最重要的并发症,主要源于术后残留晶状体上皮细胞(LEC)的黏附、增殖和转分化。以往的研究主要集中在IOL的亲水性表面修饰以预防PCO,如肝素化。然而,长期临床研究表明,未处理的IOL和肝素化IOL之间没有显著差异。在本研究中,通过简便的多巴胺自聚合反应,设计并在IOL表面修饰了一种具有药物洗脱和亲水性的协同涂层。当在IOL表面形成聚多巴胺(PDA)涂层时,负载抗增殖药物阿霉素(DOX)。随后,亲水性的2-甲基丙烯酰氧基乙基磷酰胆碱(MPC)可以很容易地接枝到载药PDA涂层表面。亲水性外层可以减缓药物从含药涂层下方洗脱。研究表明,这种多功能涂层修饰的IOL不仅可以通过诱导细胞凋亡彻底有效地预防PCO的发展,还能为周围组织提供安全性和生物相容性。